menu search

Aridis Provides Corporate Update

Aridis Provides Corporate Update
LOS GATOS, Calif., March 31, 2023 (GLOBE NEWSWIRE) — Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, today announced a corporate update on recent developments. The Company received written notice from MedImmune Limited (“MedImmune”) terminating a certain license covering AR-320, a product candidate currently being evaluated for the prevention of Ventilator Acquired […] The post Aridis Provides Corporate Update appeared first on ForexTV... Read More
Posted: Mar 31 2023, 23:00
Author Name: forextv
Views: 102764

Search within

Pages Search Results: